Blog

When it comes to Social Security, people tend to fall into one of two camps. Either they plan to rely on it to cover the vast majority of their retirement expenses, or they believe it won't be

Axsome Therapeutics (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel treatments for central nervous system disorders, saw its shares gain as much as 84% in pre-market

Shares of Amarin (NASDAQ: AMRN) jumped by as much as 11.7% in pre-market trading Monday morning. What's driving this sizable move higher ahead of the opening bell?

On Friday, Amarin announced that

The health insurance industry has gone through a lot of turmoil over the past several years, as lawmakers in Washington have targeted insurers through various healthcare reform measures. That's kept

Leidos' (NYSE: LDOS) business is booming -- and it's about to boom even bigger.

Since its absorption of Lockheed Martin's IT division in 2016, revenue at the publicly traded IT powerhouse has more

CNH Industrial (NYSE: CNHI) quietly builds trucks, tractors, farm and construction vehicles, buses, and even amphibious armored vehicles -- machines that keep modern life functioning but usually

Healthcare is one of those expenses that's frustratingly unavoidable, but detrimentally expensive. It's so expensive, in fact, that medical debt is the No. 1 source of personal bankruptcy filings in

As the end of the year approaches, tax season is almost upon us once again. Once January comes, many people will start clamoring to get their tax returns done as soon as possible to try to get their

It's been a dismal year for marijuana stocks tied to large scale cannabis producers, but ancillary businesses that serve the industry are having a banner year. A lack of profits hasn't stopped

The push to develop new medicines isn't taking a break for the holiday season. In fact, the rest of December could be a busy couple of weeks.

All of these drugmakers are expecting big catalysts that

Enterprise Products Partners (NYSE: EPD) pays its investors well. The energy company yields 6.3% at the moment. That's well above the average of dividend stocks in the S&P 500, which is around 2%

Last week, EnWave (TSXV: ENW) (OTC: NWVCF) reported fourth-quarter and full-year results for fiscal 2019. For the quarter, the cannabis player's revenue soared 120% year over year. It broke even on

Millions of seniors rely on Medicare to cover their health-related needs in retirement. But one major misconception about Medicare is that the program is entirely free. In reality, it's very

In just over two weeks when we turn the page on 2019, it'll almost certainly go down as the worst year on record for marijuana stocks. What began as a very promising year that saw more than a dozen

Investors have been happy with Nike's (NYSE: NKE) business performance so far this year. The footwear and sports apparel giant has overcome rising costs and new competition in both the online and

When 2019 began, it was expected to be an incredibly "green" year for the cannabis industry. Canada had just commenced recreational weed sales in October 2018; higher-margin derivative products were

The concept of early retirement has really taken off. Read the news, and you'll hear some story of a thirty- or fortysomething couple quitting their jobs to spend the rest of their lives traveling.

It's been a long wait, but Boeing (NYSE: BA) is finally, almost, ready to go back to space -- bringing astronauts along for the ride.

On December 20, 2019, at an hour yet to be announced, Boeing

Not for the first time lately, the stock market traded more or less sideways last week. Ultimately, despite the occasional peak and valley, investors in many top stocks didn't see the value of their

The tax law changes that took effect in 2018 were tough for taxpayers to get used to. With brand new tax forms and big changes to key aspects of the tax system, including tax rates, the size of the

Finding a good dividend stock can be challenging, because investors must consider multiple factors. An important one is dividend growth. The three companies listed below have all raised their

Stereotaxis' (NYSE: STXS) poor financial management certainly disappointed investors during its first attempt at a public listing, even after a much-hyped initial public offering (IPO) in 2004. The

If you like the idea of convenience, low cost, and professional assistance in your financial life, you should be quite interested in mutual funds. Don't just buy any old funds, though, and don't

In just 16 days, we'll officially be ushering in a new year and a new decade. That means for tens of millions of Americans, it's once again resolution time.

For most Americans, New Year's

Chances are, you'll wind up relying on Social Security to a pretty substantial degree in retirement. Losing out on money in your benefits is therefore the last thing you want to do. But if you fall